Lutetium LU 177 (LUTATHERA)

Ended Awarded Last action

Contract number
36C26322F0003
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value 0% obligated
  • $299,257.12 Current, with exercised options
  • $598,514.24 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
New York, NY 10118, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Deobligation of funds. -$299,257
Original award $299,257

About this award

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $598,514 delivery order to Advanced Accelerator Applications USA Inc. for the radiopharmaceutical Lutetium Lu 177 under the company's Pharmaceuticals and Drugs GSA Schedule. Performance will take place in New York, NY over one year beginning October 1, 2021. This appears to be a firm fixed price order for Lutetium Lu 177, which is used as a therapeutic radiopharmaceutical in the treatment of neuroendocrine tumors. The contract was awarded utilizing the company's existing Pharmaceuticals and Drugs GSA Schedule, which allows federal agencies to procure off-the-shelf products and services at pre-negotiated prices. No subcontractors or set-aside designations were identified.

Quick answers

Who was awarded contract 36C26322F0003?

36C26322F0003 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 1, 2021.

How much is contract 36C26322F0003 worth?

The government has obligated $0 on 36C26322F0003. Its current value, with exercised options, is $299,257. Its potential value, with all options, is $598,514.

Is contract 36C26322F0003 an order under another contract?

Yes. 36C26322F0003 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26322F0003 competed?

The extent of competition for 36C26322F0003 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award